Optiver Holding’s Blueprint Medicines BPMC Stock Holding History

Optiver Holding’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-412	Closed	-$52.8K	–	2699
2025 Q2	$52.8K	Buy	412 +103	+33%	+$10.7K	﹤0.01%	614
2025 Q1	$27.4K	Buy	+309	New	+$30.1K	﹤0.01%	616

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Optiver Holding's BPMC Position: Q3 2025 in Review

Optiver Holding sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 412 shares — an estimated $52.8K sold.

Optiver Holding first reported a position in BPMC in Q1 2025 and held it in 2 quarters. The position peaked at $52.8K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

Optiver Holding reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
Optiver Holding sold 412 Blueprint Medicines shares in Q3 2025, an estimated $52.8K.
Optiver Holding first reported a position in Blueprint Medicines in Q1 2025 and held it in 2 quarters.
Optiver Holding's Blueprint Medicines position peaked at $52.8K in Q2 2025.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Optiver Holding's 13F filing for Q3 2025, filed 10 Nov 2025.